top of page
home page photo.jpg

Diagnostics to
Enhance Your Everyday

WHO WE ARE

OHC is fierce about responding rapidly to emerging diagnostic needs with innovations for testing in all settings, offering a full range of solutions from rapid at-home testing to point-of-care and lab based molecular systems. We are proud of our relentless focus on quality, service, and R&D responsiveness.

​

OHC has been a leader in the in vitro diagnostic (IVD) industry since our founding in 1996. We strive towards ever expanding a robust array of medical devices for biochemical, immunological, and molecular diagnostics. Today, we export diagnostic sensors, IVD tests, and immunoassay devices to more than 110 countries around the world. With the combination of innovative technology and diagnostics, our mission is to develop the right test platform to produce the right solution. 

WHAT WE DO

Molecular Diagnostics
Asset 8_4x.png
Broad Portfolio of Single-Target
and Multi-Target Infectious Disease Genefinder™ PCR Tests Compatible

​

  • 15+ tests

  • EX-Mate 32 Plus
    (extraction equipment)

  • Custom design and
    manufacturing

Immunological Diagnostics
Asset 2_3x.png
Global Expert in Design, Manufacturing, and Distribution of Immunodiagnostics Platforms and Assays

​

  • COVID-19/Influenza A&B

  • SelexON (Human & Vetrinary)

  • Custom design

  • Custom labeling

Biological Diagnostics
Asset 4_3x.png
Comprehensive Solutions to Measure Substances Produced by Various Metabolism in the Body

​

  • Blood Glucose Meter

  • Glycopoietic Pigment Measuring Instrument

  • Cholesterol Meter

  • Liver Disease Detector

Science Lab

WHY OHC?

Global Reach

 

Millions of Tests Performed In 100+ Countries

Broad Portfolio Of Single Target And Multi-Target Infectious Disease Genefinder™ PCR Tests Compatible

​

  • 15+ tests

  • EX-Mate 32 Plus
    (extraction equipment)

  • Custom design and manufacturing

SCR-20221030-ogr_edited.jpg
Manufacturing Quality

​

Registrations for:

 

  • 01ISO 90

  • ISO 13485

  • KGMP

  • MDSAP 

SCR-20221030-ogr_edited.jpg
SCR-20221030-ogl_edited.jpg
Broad IP Portfolio

​

189 Patents Issued Worldwide

COVID-19-Antigen-Self-Test.png

Leaders In COVID-19
Testing

The OHC COVID-19 Antigen Self Test is a lateral flow assay intended for the qualitative detection of COVID-19 in nasal swab samples collected from individuals within 7 days of the onset of symptoms or infected individuals without symptoms.  LEARN MORE >

​

Note: For in vitro diagnostic use only. For use under FDA EUA only.

Layer 1.png
Rapid Self Testing
Anytime, Anywhere
Layer 2.png
Quality Manufacturing
at a Significant Scale
Layer 3.png
Trusted And Tested

FDA Approved
NIH RADx Graduate
NIH ITAP Graduate

Layer 4.png
Comprehensive

Detects Known

SARS-Cov-2 Clinical Variants

Robust. Single-Tube.
Cost-Effective.

Leverage your existing real-time PCR instruments to seamlessly integrate the reliable and affordable GeneFinder

COVID-19 Plus RealAmp test into your

lab workflow.

​

Note: For in vitro diagnostic use only. For use under FDA EUA only.

SCR-20221030-oi3.jpeg

Responsive To Emerging Health Challenges

Prepare Your Lab For Monkeypox With GeneFinder™

OHC rapidly developed a research use only GeneFinder™ Monkeypox Virus (MPXV) RealAmp Kit in response to the growing threat of a monkeypox virus epidemic. This single-tube PCR test is compatible with common real-time PCR platforms for the qualitative detection of non-variola orthopoxvirus species, of which Monkeypox virus (MPXV) is a member.

​

Note: For in vitro diagnostic use only. For use under FDA EUA only.

We Are Actively Seeking Partners

We are actively seeking sales, distribution, and lab partners that are looking to expand their portfolio and grow their revenue with a strong company that delivers high-quality, economical diagnostics.

Sales Agent Partners
SCR-20221030-oih_edited.jpg
Distribution Partners
SCR-20221030-oio_edited.jpg
Lab Partners
bottom of page